# Xofluza

NDC: 85766-058
Generic name: BALOXAVIR MARBOXIL
Labeler / Manufacturer: Sportpharm LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20181024

FDA application: NDA210854

## Active ingredients

- BALOXAVIR MARBOXIL: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85766-058"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85766-058
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b58b2899-4d22-41e1-8f0c-bdead8917694